Taking Aim at the Compounding Market What makes this report particularly fascinating from an industry perspective is WWs willingness to throw a sharp elbow at its digital health competitors.In the report, WW explicitly calls out telehealth giant Hims & Hers
Polycystic Ovary Syndrome (PCOS) is a common hormonal disorder among women of reproductive age, and its common symptoms include: Irregular or absent menstrual cycles
In this article, well break down: What each drug does Why stacking them could accelerate results How they compare to Ozempic vs Retatrutide Whats next for this next-generation treatment Key Takeaways Retatrutide is a triple-hormone agonist (GLP-1/GIP/glucagon) showing record-breaking fat-loss results in clinical trials
Why should you choose Second Nature over other medication providers if youve decided to try Mounjaro (assuming youre eligible)
lactis Bi-07 reduced bloating severity by 39% vs 5% placebo
Employer Strategies SmithRx Key Takeaways GLP-1s (Ozempic, Wegovy, Mounjaro) are now being used for weight loss, sharply increasing utilization and employer drug spend
